Nitric Oxide Levels Were Associated With Postoperative Delirium Following Cardiac Surgery

NCT ID: NCT06748391

Last Updated: 2025-01-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1939 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-01

Study Completion Date

2024-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a single-center prospective observational study conducted at the operating room, post-anesthesia care unit, and ICU of Tongji Hospital, from April 2023 to September 2024.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study focused on adult patients undergoing cardiac surgery. Patients meeting the following criteria were excluded from the study: 1) age ≤ 18; 2) pregnant women; 3) individuals with preexisting preoperative delirium or a history of psychiatric disorders like schizophrenia and major depressive conditions; 4) those with an extensive history of psychotropic medications; 5) Use of nitrates after admission; and 6) patients with significant neurological disorders, such as severe traumatic brain injuries or recent strokes within the past 6 months. Blood samples were collected from patients at three different time points - pre-surgery after fasting, during surgery, and 24 hours post-surgery. These samples were stored in a central biobank at -80°C for future analysis. Details regarding the type and duration of anesthesia administered were also documented. Plasma nitric oxide (NO) levels were assessed using ethylenediaminetetraacetic acid whole blood samples (BTK074, Bio-swamp, Wuhan, China), with specific assay protocols accessible at https://www.bio-swamp.com/goodsDetail/BTK074.

Collection of research variables The research variables comprised nutritional indices, encompassing fasting blood glucose (GLU), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC), triglycerides (TG), albumin (ALB), and lymphocyte count (LYC). Initial test results for these indices were obtained within 48 hours of each patient's hospital admission. In instances where data was missing, the corresponding values recorded in the patient's medical records within the past 6 months were utilized. Furthermore, additional clinical data included gender, age, comorbidities, and treatment protocols. Comorbidities assessed comprised hypertension, diabetes, chronic lung disease, and chronic renal failure. Chronic lung diseases encompassed chronic obstructive pulmonary disease, bronchial asthma, chronic bronchitis, and bronchiectasis.

Definition and setting of clinical outcomes The primary outcome, set as patients developing POD within 7 days post-surgery or before discharge, was assessed. In the derivation cohort, delirium diagnosis relied on documented POD in the medical records. If not explicitly stated, POD presence was determined based on the Confusion Assessment Method for Intensive Care Unit (CAM-ICU) results as recorded in nursing documentation. In the prospective cohort, trained physicians utilized the CAM-ICU protocol to assess patients' consciousness at 6-hour intervals for up to 7 days postoperatively, classifying a patient with positive CAM-ICU at least once during this period or before discharge as having POD.

Secondary outcomes included common postoperative adverse events such as prolonged mechanical ventilation (MV) (defined as continuous mechanical ventilation for ≥72 hours post-surgery), in-hospital all-cause mortality, and the occurrence of postoperative pulmonary complications (e.g., respiratory infection, respiratory failure, pleural effusion, pulmonary atelectasis, pneumothorax, bronchospasm, and aspiration pneumonia). Data collection and diagnostic processes were conducted independently by two researchers, with discrepancies resolved by a third researcher to ensure accuracy and consistency.

Machine Learning Processes Machine learning techniques were implemented using Python (version 3.13.0, Python Software Foundation). Data preprocessing commenced, starting with outlier processing using the 99% Winsorisation technique to address outliers' impact on the results. StandardScaler was then applied to normalize the dataset. Spearman's correlation coefficient was employed to evaluate the correlation among dataset features, visualized using a heatmap. The K-Means clustering algorithm, a pivotal unsupervised learning method, was utilized\[15\]. K-Means models were trained on derived cohorts, and the silhouette coefficient method determined the optimal cluster number for robust clustering outcomes. The validation set data underwent classification using the pre-trained K-Means model to predict cluster labels for each sample point.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Delirium Post-operative Delirium

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cardiac Surgery

The study focused on adult patients undergoing cardiovascular surgery. Patients meeting the following criteria were excluded from the study: 1) minors under the age of 18; 2) pregnant women; 3) individuals with preexisting preoperative delirium or a history of psychiatric disorders like schizophrenia and major depressive conditions; 4) those with an extensive history of psychotropic medications; 5) Use of nitrates after admission; and 6) patients with significant neurological disorders, such as severe traumatic brain injuries or recent strokes within the past 6 months.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients undergoing cardiac surgery

Exclusion Criteria

* 1\) minors under the age of 18; 2) pregnant women; 3) individuals with preexisting preoperative delirium or a history of psychiatric disorders like schizophrenia and major depressive conditions; 4) those with an extensive history of psychotropic medications; 5) Use of nitrates after admission; 6) patients with significant neurological disorders, such as severe traumatic brain injuries or recent strokes within the past 6 months.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tongji Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Qin Zhang

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Qin Zhang, phd

Role: PRINCIPAL_INVESTIGATOR

Tongji Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TJ-IRB20231166

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.